Clinical Trials Logo

Recurrent Kaposi's Sarcoma clinical trials

View clinical trials related to Recurrent Kaposi's Sarcoma.

Filter by:
  • None
  • Page 1

NCT ID: NCT00019188 Completed - Clinical trials for Epidemic Kaposi's Sarcoma

Interleukin-12 in Treating Patients With AIDS-Related Kaposi's Sarcoma

Start date: January 1997
Phase: Phase 1/Phase 2
Study type: Interventional

RATIONALE: Interleukin-12 may kill tumor cells by stopping blood flow to the tumor and by stimulating a person's white blood cells to kill their tumor cells. PURPOSE: Phase I/II trial to study the effectiveness of interleukin-12 in treating patients with AIDS -related Kaposi's sarcoma.